BackTC BioPharm (Holdings) plc - Warrants (08/02/2027) Overview

TC BioPharm (Holdings) plc - Warrants (08/02/2027) Receivables

Latest receivables for TCBPW: $1.3M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$1.31M
↓ 48.35% YoYΔ $-1.23M vs prior year quarter

Peer average

Loading

TC BioPharm (Holdings) plc - Warrants (08/02/2027) Receivables History

Loading

TC BioPharm (Holdings) plc - Warrants (08/02/2027) vs. peers: Receivables Comparison

Loading

TC BioPharm (Holdings) plc - Warrants (08/02/2027) Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

TC BioPharm (Holdings) plc - Warrants (08/02/2027) (TCBPW) FAQ

As of the most recent data (June 2024), TCBPW shows a receivables of $1.3M. That compares with $2.5M in the prior-year period — down 48.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, TCBPW's receivables is now $1.3M (was $2.5M) — a 48.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether TC BioPharm (Holdings) plc - Warrants (08/02/2027) is outperforming or lagging.

Tracking TCBPW's receivables over time shows whether TC BioPharm (Holdings) plc - Warrants (08/02/2027) is scaling, shrinking, or reshaping that part of the business. The current reading is $1.3M That compares with $2.5M in the prior-year period — down 48.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has TC BioPharm (Holdings) plc - Warrants (08/02/2027)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $1.3M) with ownership activity and broader fundamentals.